Related references
Note: Only part of the references are listed.Prognostic Significance of the Ratio of Absolute Neutrophil Count to Absolute Lymphocyte Count in Classic Hodgkin Lymphoma
Young Wha Koh et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
Third Universal Definition of Myocardial Infarction
Kristian Thygesen et al.
CIRCULATION (2012)
Relationship Between Lymphocytopenia and Circulating Tumor Cells as Prognostic Factors for Overall Survival in Metastatic Breast Cancer
Ugo De Giorgi et al.
CLINICAL BREAST CANCER (2012)
Third universal definition of myocardial infarction
Kristian Thygesen et al.
EUROPEAN HEART JOURNAL (2012)
Third Universal Definition of Myocardial Infarction
Kristian Thygesen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Absolute monocyte/lymphocyte count prognostic score is independent of immunohistochemically determined cell of origin in predicting survival in diffuse large B-cell lymphoma
Luis F. Porrata et al.
LEUKEMIA & LYMPHOMA (2012)
The Ratio of the Absolute Lymphocyte Count to the Absolute Monocyte Count Is Associated with Prognosis in Hodgkin's Lymphoma: Correlation with Tumor-Associated Macrophages
Young Wha Koh et al.
ONCOLOGIST (2012)
Macrophages predict treatment outcome in Hodgkin's lymphoma
Christian Steidl et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Molecular Pathogenesis of Hodgkin's Lymphoma: Increasing Evidence of the Importance of the Microenvironment
Christian Steidl et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas.
Anas Younes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
Christian Steidl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Circulating clonotypic B cells in classic Hodgkin lymphoma
Richard J. Jones et al.
BLOOD (2009)
Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas
Isabelle Ray-Coquard et al.
CANCER RESEARCH (2009)
Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma
Sabine Schreck et al.
HEMATOLOGICAL ONCOLOGY (2009)
Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22
Marijke Niens et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Late effects in survivors of Hodgkin and non-hodgkin lymphoma treated with autologous hematopoietic cell transplantation: A report from the bone marrow transplant survivor study
Navneet S. Majhail et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Shedding of syndecan-1 by stromal fibroblasts stimulates human breast cancer cell proliferation via FGF2 activation
Gui Su et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Serum levels of syndecan-1 in B-cell chronic lymphocytic leukemia: Correlation with the extent of angiogenesis and disease-progression risk in early disease
Stefano Molica et al.
LEUKEMIA & LYMPHOMA (2006)
B-cell differentiation immunophenotypes in classical Hodgkin lymphomas
M Bai et al.
LEUKEMIA & LYMPHOMA (2006)
The expression of fibroblast growth factors and their receptors in Hodgkin's lymphoma
D Khnykin et al.
JOURNAL OF PATHOLOGY (2006)
Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease
MC Kyrtsonis et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2004)
CD138 (Syndecan-1), a plasma cell marker - Immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms
FP O'Connell et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2004)
Prognostic value of syndecan-1 expression in breast cancer
M Leivonen et al.
ONCOLOGY (2004)
High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis
M Barbareschi et al.
CANCER (2003)
Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in pro-state cancer
T Zellweger et al.
PROSTATE (2003)
Diverse role of MMP-2 and MMP-9 in the clinicopathological behavior of Hodgkin's lymphoma
O Kuittinen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2002)
The role of cytokines in classical Hodgkin lymphoma
BF Skinnider et al.
BLOOD (2002)
Expression of basic fibroblast growth factor is associated with poor outcome in non-Hodgkin's lymphoma
I Pazgal et al.
BRITISH JOURNAL OF CANCER (2002)
Shedding of syndecan-1 and-4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase
ML Fitzgerald et al.
JOURNAL OF CELL BIOLOGY (2000)
Hodgkin disease: prognostic factors and treatment strategies
A Josting et al.
CURRENT OPINION IN ONCOLOGY (2000)
Share Paper
